We are international
Donate
•about myeloma    TEXT SIZE   
publications    back

THE INTERNATIONAL MYELOMA FOUNDATION SAYS PREVIOUSLY UNTREATED PATIENTS COULD BENEFIT FROM FDA APROVAL OF VELCADE® FOR 'FRONT-LINE' USE
New Indication Provides Treatment-Free Interval As an Option
06.23.08

Be the first to comment

 related articles